What’s With the Lack of Price Competition in Brand Name Cardiovascular Drugs?
A Research Letter in JAMA highlights the lack of price competition in brand name cardiovascular drugs which significantly impacts patient care. “Trends in Within-Class Changes in US Average Wholesale Prices for Brand-Name…